BCR-ABL/ABL RATIO INCREASE THAT CORRESPONDS TOPRESENCEOFBCR-ABL MUTATION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED BY IMATINIB

被引：0
|
作者：
Tsaur, G. [1 ]
Ivanova, A. [1 ]
Popov, A. [1 ]
Yakovleva, Y. [1 ]
Riger, T. [1 ]
Ivanets, Y. [2 ]
Misyurin, A. [3 ]
Suchkova, M. [3 ]
Shorikov, E. [1 ]
Saveliev, L. [4 ]
Fechina, L. [1 ]
机构：
[1] Reg Childrens Hosp, Res Inst Med Cell Technol, Pediat Oncol & Hematol Ctr, Ekaterinburg, Russia
[2] Novartis Pharmaceut, BU Oncol, Ekaterinburg, Russia
[3] Minist Publ Hlth Russia, Hematol Res Ctr, Lab Gene Engn, Moscow, Russia
[4] Ural State Med Acad, Chair Lab Med, Ekaterinburg, Russia
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2011年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：S490 / S490
页数：1
相关论文
共 50 条
  • [31] Influence of BCR-ABL Transcript Type on Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib
    Barbosa Pagnano, Katia Borgia
    Miranda, Eliana Cristina
    Delamain, Marcia Torresan
    Duarte, Gislaine Oliveira
    de Paula, Erich Vinicius
    Lorand-Metze, Irene
    de Souza, Carmino Antonio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (11): : 728 - 733
  • [32] Specific assessment of BCR-ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients
    Bianchini, Michele
    De Brasi, Carlos
    Gargallo, Patricia
    Gonzalez, Mariana
    Bengio, Raquel
    Larripa, Irene
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (04) : 292 - 300
  • [33] Spectrum of BCR-ABL mutations in Azerbaijanian imatinib-resistant patients with chronic myeloid leukemia
    Hasanova, Aypara
    Asadov, Chingiz
    Karimova, Nigar
    Shirinova, Aytan
    Aliyeva, Gunay
    Alimirzoyeva, Zohra
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [34] Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts
    Sharma, Pratibha
    Kumar, Lalit
    Mohanty, Sujata
    Kochupillai, Vinod
    ANNALS OF HEMATOLOGY, 2010, 89 (03) : 241 - 247
  • [35] Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts
    Pratibha Sharma
    Lalit Kumar
    Sujata Mohanty
    Vinod Kochupillai
    Annals of Hematology, 2010, 89 : 241 - 247
  • [36] Characteristics of BCR-ABL gene variants in patients of chronic myeloid leukemia
    Amin, Huma
    Ahmed, Suhaib
    OPEN MEDICINE, 2021, 16 (01): : 904 - 912
  • [37] BCR-ABL independent gene mutations in patients with chronic myeloid leukemia
    Schmidt, M.
    Rinke, J.
    Schaefer, V.
    Ziermann, J.
    Eigendorff, E.
    Hochhaus, A.
    Ernst, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 210 - 210
  • [38] Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib
    Press, Richard D.
    Willis, Stephanie G.
    Laudadio, Jennifer
    Mauro, Michael J.
    Deininger, Michael W. N.
    BLOOD, 2009, 114 (13) : 2598 - 2605
  • [39] BALANCED PARENTAL CONTRIBUTION TO THE ABL COMPONENT OF THE BCR-ABL GENE IN CHRONIC MYELOID-LEUKEMIA
    MELO, JV
    YAN, XH
    DIAMOND, J
    GOLDMAN, JM
    LEUKEMIA, 1995, 9 (04) : 734 - 739
  • [40] Molecular deregulations mediated by Bcr-Abl in chronic myeloid leukemia
    Chomel, JC
    Guilhot, F
    Tanzer, J
    Kitzis, A
    M S-MEDECINE SCIENCES, 1995, 11 (12): : 1669 - 1678
12345